ArticleJournal of imaging informatics in medicine2026
A Fluorescence Imaging- and Deep Learning-Based Approach for Detecting Hepatitis B Virus Integration into Host Genomes.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Hepatitis B virus (HBV) infection can lead to hepatocellular carcinoma, and HBV integration into the host genome is regularly observed in the liver of chronic HBV carriers and is speculated to trigger carcinogenesis. To detect HBV integration, PCR-based methods are sensitive but may not be effective depending on the HBV integration site. High-throughput sequencing reveals not only HBV integration but also the site. However, it is still expensive for clinical applications. In situ hybridization is efficient and allows detection of DNA and RNA in single cells and has been applied to study HBV infection and dynamics. The technique, however, has not been applied to detect HBV integration. The task is challenging because of the small copy number of integrated HBV genomes, which results in a small signal-to-noise ratio. Here, we developed a fluorescence in situ hybridization approach for examining HBV integration in each liver cell. The obtained images of cells were analyzed using a deep learning model. Using several hepatoma cell lines with and without integrated HBV DNA, we showed that our trained neural network achieved an over 90% accuracy for majority of positive and negative control cells. This is the first proof-of-concept study showing that fluorescence imaging and deep learning are useful in detecting HBV integration at the single-cell level.
Indexed as
Identifiers
42151659What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.